CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-010427
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 DNA-dependent protein kinase catalytic subunit 
Protein Synonyms/Alias
 DNA-PK catalytic subunit; DNA-PKcs; DNPK1; p460 
Gene Name
 PRKDC 
Gene Synonyms/Alias
 HYRC; HYRC1 
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
71GLLVFVRKSLNSIEFubiquitination[1]
99FLEKMGQKIAPYSVEubiquitination[1, 2]
108APYSVEIKNTCTSVYubiquitination[1, 3, 4]
117TCTSVYTKDRAAKCKacetylation[5]
117TCTSVYTKDRAAKCKubiquitination[1, 2, 6, 7]
122YTKDRAAKCKIPALDubiquitination[1]
124KDRAAKCKIPALDLLubiquitination[1]
148SRLMDEFKIGELFSKubiquitination[1, 2]
155KIGELFSKFYGELALubiquitination[1, 2]
163FYGELALKKKIPDTVubiquitination[1, 2]
164YGELALKKKIPDTVLubiquitination[1]
165GELALKKKIPDTVLEubiquitination[1]
205RAFLGELKTQMTSAVubiquitination[1, 2, 3, 4]
216TSAVREPKLPVLAGCubiquitination[1]
225PVLAGCLKGLSSLLCubiquitination[2]
236SLLCNFTKSMEEDPQubiquitination[1, 6, 7]
254EIFNFVLKAIRPQIDacetylation[5]
254EIFNFVLKAIRPQIDubiquitination[1, 2, 3, 4, 6]
263IRPQIDLKRYAVPSAubiquitination[1, 2, 3, 4, 6, 7]
310HTNVELKKAALSALEubiquitination[1, 2, 3, 4]
329QVSNMVAKNAEMHKNubiquitination[2]
337NAEMHKNKLQYFMEQubiquitination[2]
357RNVDSNNKELSIAIRubiquitination[1, 2, 3, 4, 8]
374GLFAGPCKVINAKDVubiquitination[1, 6]
379PCKVINAKDVDFMYVubiquitination[1, 2]
393VELIQRCKQMFLTQTubiquitination[1]
471VFLALAAKGPVLRNCubiquitination[1, 2, 3, 4, 6]
493GLIRICSKPVVLPKGubiquitination[1, 6, 7]
499SKPVVLPKGPESESEubiquitination[1]
520EVRTGKWKVPTYKDYubiquitination[1]
525KWKVPTYKDYVDLFRubiquitination[1, 2, 3, 4, 6, 8]
574EFVKSVLKIVEKLDLubiquitination[1, 2]
668PLISGFYKLLSITVRubiquitination[2]
679ITVRNAKKIKYFEGVubiquitination[1]
681VRNAKKIKYFEGVSPubiquitination[1, 2, 3, 4]
689YFEGVSPKSLKHSPEubiquitination[1, 2, 3, 4, 6, 7]
692GVSPKSLKHSPEDPEubiquitination[1, 2]
700HSPEDPEKYSCFALFubiquitination[1]
712ALFVKFGKEVAVKMKubiquitination[1, 2]
717FGKEVAVKMKQYKDEubiquitination[1, 2]
790HVMQPYYKDILPCLDubiquitination[1]
801PCLDGYLKTSALSDEubiquitination[1, 3, 4, 6]
810SALSDETKNNWEVSAubiquitination[1, 2, 3, 4, 6, 7, 8]
824ALSRAAQKGFNKVVLubiquitination[1]
828AAQKGFNKVVLKHLKacetylation[5]
828AAQKGFNKVVLKHLKubiquitination[1, 7]
832GFNKVVLKHLKKTKNacetylation[5]
832GFNKVVLKHLKKTKNubiquitination[1, 3, 4]
836VVLKHLKKTKNLSSNubiquitination[1]
838LKHLKKTKNLSSNEAubiquitination[1, 2, 3, 4, 7, 8]
868SLGGQINKNLLTVTSubiquitination[1, 2, 7]
881TSSDEMMKSYVAWDRubiquitination[1, 2]
890YVAWDREKRLSFAVPubiquitination[1]
902AVPFREMKPVIFLDVubiquitination[1, 2]
927TASDRQTKVAACELLubiquitination[2]
963PPMYQLYKRTFPVLLubiquitination[1, 2, 3, 4, 6, 7]
1038RCIREFLKWSIKQITubiquitination[1, 3, 4]
1042EFLKWSIKQITPQQQubiquitination[1, 2, 3, 4, 6, 7]
1051ITPQQQEKSPVNTKSubiquitination[1, 2, 7]
1057EKSPVNTKSLFKRLYacetylation[5]
1057EKSPVNTKSLFKRLYubiquitination[1, 2, 6, 7]
1074ALHPNAFKRLGASLAubiquitination[1, 2, 3, 4, 8]
1147KKHVSLNKAKKRRLPubiquitination[7]
1150VSLNKAKKRRLPRGFmethylation[9]
1186PQTECRHKSIELFYKubiquitination[1, 2]
1193KSIELFYKFVPLLPGubiquitination[1, 2, 6]
1209RSPNLWLKDVLKEEGacetylation[5]
1209RSPNLWLKDVLKEEGubiquitination[1, 2, 3, 4, 8]
1311HDIIAAEKCFGTGAAubiquitination[2]
1334GERYNYSKCTVVVRIubiquitination[1, 2, 6, 7]
1357NTSPEGWKLLKKDLCubiquitination[1, 2]
1360PEGWKLLKKDLCNTHubiquitination[1]
1361EGWKLLKKDLCNTHLubiquitination[1]
1407VNLMKALKMSPYKDIubiquitination[1, 2]
1412ALKMSPYKDILETHLubiquitination[1, 2, 3, 4]
1422LETHLREKITAQSIEubiquitination[1, 6, 7]
1456AAVVSACKQLHRAGLubiquitination[1, 2, 6, 7, 8]
1489ELLSLVYKGIAPGDEubiquitination[1, 2]
1612FRERANQKHQGLKLAubiquitination[2]
1617NQKHQGLKLATTILQubiquitination[1]
1627TTILQHWKKCDSWWAubiquitination[1, 2, 3, 4]
1628TILQHWKKCDSWWAKubiquitination[1]
1635KCDSWWAKDSPLETKubiquitination[1]
1642KDSPLETKMAVLALLubiquitination[1, 2]
1744NNYVDCMKKFLDALEubiquitination[1, 7]
1807SVYEMFRKDDPRLSFubiquitination[1]
1857VLKSRFTKLNESTFDubiquitination[1, 2, 3, 4, 7]
1869TFDTQITKKMGYYKIubiquitination[1, 2, 3, 4, 7]
1870FDTQITKKMGYYKILubiquitination[1]
1875TKKMGYYKILDVMYSubiquitination[1, 2, 3, 4]
1886VMYSRLPKDDVHAKEubiquitination[1]
1892PKDDVHAKESKINQVubiquitination[1, 2]
1895DVHAKESKINQVFHGubiquitination[1, 7]
1913TEGNELTKTLIKLCYubiquitination[1, 3, 4, 7]
1970QGFLFSEKPEKNLLIacetylation[5]
1970QGFLFSEKPEKNLLIubiquitination[1, 2, 3, 4, 7]
1973LFSEKPEKNLLIFENubiquitination[3, 4]
1985FENLIDLKRRYNFPVubiquitination[1, 2, 3, 4, 6, 7, 8]
2002EVPMERKKKYIEIRKubiquitination[1]
2003VPMERKKKYIEIRKEubiquitination[1]
2102APLTALVKHMHRSLGubiquitination[1]
2127RDLPSWMKFLHGKLGubiquitination[1, 2, 3, 4]
2132WMKFLHGKLGNPIVPubiquitination[1, 2, 3, 4]
2227MKHVFHPKRAVFRHNubiquitination[2]
2239RHNLEIIKTLVECWKubiquitination[1]
2246KTLVECWKDCLSIPYubiquitination[1, 6]
2259PYRLIFEKFSGKDPNacetylation[5]
2259PYRLIFEKFSGKDPNubiquitination[1, 2, 3, 4]
2263IFEKFSGKDPNSKDNubiquitination[1, 2]
2313NMSFVRYKEVYAAAAubiquitination[1]
2334LRYVMERKNILEESLubiquitination[1, 7]
2347SLCELVAKQLKQHQNubiquitination[1, 2]
2350ELVAKQLKQHQNTMEubiquitination[1, 2]
2359HQNTMEDKFIVCLNKubiquitination[1]
2366KFIVCLNKVTKSFPPubiquitination[1, 8]
2369VCLNKVTKSFPPLADubiquitination[2, 3, 4, 8]
2418LYFQLKSKDFVQVMRubiquitination[1, 2]
2433HRDDERQKVCLDIIYubiquitination[1]
2441VCLDIIYKMMPKLKPubiquitination[1, 7]
2445IIYKMMPKLKPVELRubiquitination[1, 3, 4]
2447YKMMPKLKPVELRELubiquitination[1, 2, 3, 4]
2500NDSQEIFKLAKDVLIubiquitination[2]
2503QEIFKLAKDVLIQGLubiquitination[1, 2, 6]
2683DSLLFAHKRSERLQRubiquitination[1, 2, 3, 4, 7]
2694RLQRAPLKSVGPDFGubiquitination[1, 2, 3, 4, 7]
2702SVGPDFGKKRLGLPGacetylation[5]
2702SVGPDFGKKRLGLPGubiquitination[1, 2]
2703VGPDFGKKRLGLPGDubiquitination[1]
2715PGDEVDNKVKGAAGRubiquitination[1, 2, 7]
2717DEVDNKVKGAAGRTDubiquitination[1, 7]
2738RFMRDQEKLSLMYARubiquitination[1, 3, 4, 7, 8]
2746LSLMYARKGVAEQKRmethylation[9]
2755VAEQKREKEIKSELKubiquitination[1]
2758QKREKEIKSELKMKQubiquitination[1]
2764IKSELKMKQDAQVVLubiquitination[1, 2, 7]
2786DLPDIQIKHSSLITPubiquitination[1, 2, 3, 4]
2806QRDPIIAKQLFSSLFubiquitination[2, 3, 4]
2818SLFSGILKEMDKFKTubiquitination[1]
2829KFKTLSEKNNITQKLubiquitination[1, 2]
2835EKNNITQKLLQDFNRubiquitination[1, 2, 3, 4, 8]
2908LPAELPAKRVRGKARubiquitination[1, 2, 3, 4, 6, 7, 8]
2928LRWVELAKLYRSIGEubiquitination[1, 2, 3, 4, 6, 7, 8]
2950FTSEIGTKQITQSALubiquitination[1, 2, 3, 4, 6, 7, 10]
2970SDYSEAAKQYDEALNubiquitination[1, 2]
2978QYDEALNKQDWVDGEubiquitination[2]
3050YMIRSKLKLLLQGEAubiquitination[2]
3067SLLTFIDKAMHGELQubiquitination[1, 2]
3158LSSQVPLKRLLNTWTubiquitination[1, 2, 7]
3172TNRYPDAKMDPMNIWubiquitination[1, 2]
3192NRCFFLSKIEEKLTPubiquitination[1, 2, 3, 4, 6, 7]
3196FLSKIEEKLTPLPEDubiquitination[1, 2]
3235SSLIRSCKFSMKMKMubiquitination[1, 8]
3239RSCKFSMKMKMIDSAubiquitination[1]
3241CKFSMKMKMIDSARKacetylation[5]
3241CKFSMKMKMIDSARKubiquitination[1]
3248KMIDSARKQNNFSLAmethylation[9]
3248KMIDSARKQNNFSLAubiquitination[1, 2, 7]
3257NNFSLAMKLLKELHKubiquitination[1, 3, 4, 8]
3260SLAMKLLKELHKESKacetylation[5]
3260SLAMKLLKELHKESKubiquitination[1]
3264KLLKELHKESKTRDDubiquitination[1, 2]
3302EQVLTVLKTVSLLDEubiquitination[1]
3318NVSSYLSKNILAFRDubiquitination[1, 2, 3, 4, 6, 7]
3355LAEIEEDKARRILELubiquitination[1, 7]
3372SSSEDSEKVIAGLYQubiquitination[1, 2, 6]
3426FCDQQLRKEEENASVubiquitination[1, 2]
3449YPALVVEKMLKALKLubiquitination[1, 2]
3452LVVEKMLKALKLNSNubiquitination[1]
3455EKMLKALKLNSNEARubiquitination[1, 2, 7]
3550KDTSTGHKNKEFVARubiquitination[1]
3552TSTGHKNKEFVARIKubiquitination[1, 2, 3, 4, 8]
3598DVRAELAKTPVNKKNubiquitination[1]
3608VNKKNIEKMYERMYAacetylation[5]
3608VNKKNIEKMYERMYAubiquitination[1]
3621YAALGDPKAPGLGAFacetylation[5]
3621YAALGDPKAPGLGAFubiquitination[1, 2, 3, 4]
3631GLGAFRRKFIQTFGKubiquitination[1, 7]
3638KFIQTFGKEFDKHFGacetylation[5]
3638KFIQTFGKEFDKHFGubiquitination[1, 3, 4]
3642TFGKEFDKHFGKGGSacetylation[5]
3642TFGKEFDKHFGKGGSubiquitination[1]
3646EFDKHFGKGGSKLLRubiquitination[1]
3650HFGKGGSKLLRMKLSubiquitination[1]
3655GSKLLRMKLSDFNDIubiquitination[1, 7]
3669ITNMLLLKMNKDSKPubiquitination[1, 2, 3, 4]
3672MLLLKMNKDSKPPGNubiquitination[1]
3691SPWMSDFKVEFLRNEubiquitination[1]
3710GQYDGRGKPLPEYHVubiquitination[1, 2, 3, 4, 7]
3753REHPFLVKGGEDLRQubiquitination[1, 2, 3, 4, 7]
3825NTMSQEEKAAYLSDPubiquitination[1, 2, 3, 4, 11, 12]
3840RAPPCEYKDWLTKMSubiquitination[1, 3, 4]
3845EYKDWLTKMSGKHDVubiquitination[1, 2, 3, 4, 7, 8]
3849WLTKMSGKHDVGAYMubiquitination[1, 7]
3860GAYMLMYKGANRTETubiquitination[1, 2, 3, 4, 6, 8]
3877SFRKRESKVPADLLKubiquitination[1]
3884KVPADLLKRAFVRMSubiquitination[1, 2, 7]
4007NTMDVFVKEPSFDWKubiquitination[1, 2]
4014KEPSFDWKNFEQKMLubiquitination[1]
4019DWKNFEQKMLKKGGSubiquitination[1, 2]
4023FEQKMLKKGGSWIQEubiquitination[1, 2, 7]
4036QEINVAEKNWYPRQKubiquitination[1, 2, 3, 4, 7]
4043KNWYPRQKICYAKRKubiquitination[1]
4048RQKICYAKRKLAGANubiquitination[1]
4050KICYAKRKLAGANPAubiquitination[1, 7]
4070ELLLGHEKAPAFRDYubiquitination[1, 7]
4105LSEETQVKCLMDQATubiquitination[1, 7]
Reference
 [1] Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments.
 Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, Carr SA.
 Mol Cell Proteomics. 2013 Mar;12(3):825-31. [PMID: 23266961]
 [2] Systematic and quantitative assessment of the ubiquitin-modified proteome.
 Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP.
 Mol Cell. 2011 Oct 21;44(2):325-40. [PMID: 21906983]
 [3] A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.
 Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C.
 Mol Cell Proteomics. 2011 Oct;10(10):M111.013284. [PMID: 21890473]
 [4] hCKSAAP_UbSite: improved prediction of human ubiquitination sites by exploiting amino acid pattern and properties.
 Chen Z, Zhou Y, Song J, Zhang Z.
 Biochim Biophys Acta. 2013 Aug;1834(8):1461-7. [PMID: 23603789]
 [5] Lysine acetylation targets protein complexes and co-regulates major cellular functions.
 Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M.
 Science. 2009 Aug 14;325(5942):834-40. [PMID: 19608861]
 [6] Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels.
 Lee KA, Hammerle LP, Andrews PS, Stokes MP, Mustelin T, Silva JC, Black RA, Doedens JR.
 J Biol Chem. 2011 Dec 2;286(48):41530-8. [PMID: 21987572]
 [7] Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.
 Udeshi ND, Mani DR, Eisenhaure T, Mertins P, Jaffe JD, Clauser KR, Hacohen N, Carr SA.
 Mol Cell Proteomics. 2012 May;11(5):148-59. [PMID: 22505724]
 [8] Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass.
 Povlsen LK, Beli P, Wagner SA, Poulsen SL, Sylvestersen KB, Poulsen JW, Nielsen ML, Bekker-Jensen S, Mailand N, Choudhary C.
 Nat Cell Biol. 2012 Oct;14(10):1089-98. [PMID: 23000965]
 [9] Mass spectrometry-based identification and characterisation of lysine and arginine methylation in the human proteome.
 Bremang M, Cuomo A, Agresta AM, Stugiewicz M, Spadotto V, Bonaldi T.
 Mol Biosyst. 2013 Jul 30;9(9):2231-47. [PMID: 23748837]
 [10] Proteome-wide identification of ubiquitylation sites by conjugation of engineered lysine-less ubiquitin.
 Oshikawa K, Matsumoto M, Oyamada K, Nakayama KI.
 J Proteome Res. 2012 Feb 3;11(2):796-807. [PMID: 22053931]
 [11] Global identification of modular cullin-RING ligase substrates.
 Emanuele MJ, Elia AE, Xu Q, Thoma CR, Izhar L, Leng Y, Guo A, Chen YN, Rush J, Hsu PW, Yen HC, Elledge SJ.
 Cell. 2011 Oct 14;147(2):459-74. [PMID: 21963094]
 [12] Integrated proteomic analysis of post-translational modifications by serial enrichment.
 Mertins P, Qiao JW, Patel J, Udeshi ND, Clauser KR, Mani DR, Burgess MW, Gillette MA, Jaffe JD, Carr SA.
 Nat Methods. 2013 Jul;10(7):634-7. [PMID: 23749302
Functional Description
 Serine/threonine-protein kinase that acts as a molecular sensor for DNA damage. Involved in DNA nonhomologous end joining (NHEJ) required for double-strand break (DSB) repair and V(D)J recombination. Must be bound to DNA to express its catalytic properties. Promotes processing of hairpin DNA structures in V(D)J recombination by activation of the hairpin endonuclease artemis (DCLRE1C). The assembly of the DNA-PK complex at DNA ends is also required for the NHEJ ligation step. Required to protect and align broken ends of DNA. May also act as a scaffold protein to aid the localization of DNA repair proteins to the site of damage. Found at the ends of chromosomes, suggesting a further role in the maintenance of telomeric stability and the prevention of chromosomal end fusion. Also involved in modulation of transcription. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates 'Ser-139' of histone variant H2AX/H2AFX, thereby regulating DNA damage response mechanism. Phosphorylates DCLRE1C, c-Abl/ABL1, histone H1, HSPCA, c-jun/JUN, p53/TP53, PARP1, POU2F1, DHX9, SRF, XRCC1, XRCC1, XRCC4, XRCC5, XRCC6, WRN, MYC and RFA2. Can phosphorylate C1D not only in the presence of linear DNA but also in the presence of supercoiled DNA. Ability to phosphorylate p53/TP53 in the presence of supercoiled DNA is dependent on C1D. 
Sequence Annotation
 REPEAT 288 323 HEAT 1.
 REPEAT 1004 1040 HEAT 2.
 REPEAT 1723 1756 TPR 1.
 DOMAIN 2883 3539 FAT.
 REPEAT 2920 2948 TPR 2.
 REPEAT 2949 2982 TPR 3.
 DOMAIN 3747 4015 PI3K/PI4K.
 DOMAIN 4096 4128 FATC.
 REGION 1503 1538 Interaction with C1D.
 REGION 1503 1538 Leucine-zipper.
 REGION 2436 3212 KIP-binding.
 MOD_RES 117 117 N6-acetyllysine.
 MOD_RES 828 828 N6-acetyllysine.
 MOD_RES 893 893 Phosphoserine.
 MOD_RES 1209 1209 N6-acetyllysine.
 MOD_RES 1970 1970 N6-acetyllysine.
 MOD_RES 2259 2259 N6-acetyllysine.
 MOD_RES 2609 2609 Phosphothreonine; by autocatalysis.
 MOD_RES 2612 2612 Phosphoserine; by autocatalysis.
 MOD_RES 2638 2638 Phosphothreonine; by autocatalysis.
 MOD_RES 2647 2647 Phosphothreonine; by autocatalysis.
 MOD_RES 3205 3205 Phosphoserine.
 MOD_RES 3241 3241 N6-acetyllysine.
 MOD_RES 3260 3260 N6-acetyllysine.
 MOD_RES 3621 3621 N6-acetyllysine.
 MOD_RES 3638 3638 N6-acetyllysine.
 MOD_RES 3642 3642 N6-acetyllysine.
 MOD_RES 4026 4026 Phosphoserine.  
Keyword
 Acetylation; Alternative splicing; ATP-binding; Complete proteome; DNA damage; DNA recombination; DNA repair; DNA-binding; Kinase; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Repeat; S-nitrosylation; Serine/threonine-protein kinase; TPR repeat; Transferase. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 4128 AA 
Protein Sequence
MAGSGAGVRC SLLRLQETLS AADRCGAALA GHQLIRGLGQ ECVLSSSPAV LALQTSLVFS 60
RDFGLLVFVR KSLNSIEFRE CREEILKFLC IFLEKMGQKI APYSVEIKNT CTSVYTKDRA 120
AKCKIPALDL LIKLLQTFRS SRLMDEFKIG ELFSKFYGEL ALKKKIPDTV LEKVYELLGL 180
LGEVHPSEMI NNAENLFRAF LGELKTQMTS AVREPKLPVL AGCLKGLSSL LCNFTKSMEE 240
DPQTSREIFN FVLKAIRPQI DLKRYAVPSA GLRLFALHAS QFSTCLLDNY VSLFEVLLKW 300
CAHTNVELKK AALSALESFL KQVSNMVAKN AEMHKNKLQY FMEQFYGIIR NVDSNNKELS 360
IAIRGYGLFA GPCKVINAKD VDFMYVELIQ RCKQMFLTQT DTGDDRVYQM PSFLQSVASV 420
LLYLDTVPEV YTPVLEHLVV MQIDSFPQYS PKMQLVCCRA IVKVFLALAA KGPVLRNCIS 480
TVVHQGLIRI CSKPVVLPKG PESESEDHRA SGEVRTGKWK VPTYKDYVDL FRHLLSSDQM 540
MDSILADEAF FSVNSSSESL NHLLYDEFVK SVLKIVEKLD LTLEIQTVGE QENGDEAPGV 600
WMIPTSDPAA NLHPAKPKDF SAFINLVEFC REILPEKQAE FFEPWVYSFS YELILQSTRL 660
PLISGFYKLL SITVRNAKKI KYFEGVSPKS LKHSPEDPEK YSCFALFVKF GKEVAVKMKQ 720
YKDELLASCL TFLLSLPHNI IELDVRAYVP ALQMAFKLGL SYTPLAEVGL NALEEWSIYI 780
DRHVMQPYYK DILPCLDGYL KTSALSDETK NNWEVSALSR AAQKGFNKVV LKHLKKTKNL 840
SSNEAISLEE IRIRVVQMLG SLGGQINKNL LTVTSSDEMM KSYVAWDREK RLSFAVPFRE 900
MKPVIFLDVF LPRVTELALT ASDRQTKVAA CELLHSMVMF MLGKATQMPE GGQGAPPMYQ 960
LYKRTFPVLL RLACDVDQVT RQLYEPLVMQ LIHWFTNNKK FESQDTVALL EAILDGIVDP 1020
VDSTLRDFCG RCIREFLKWS IKQITPQQQE KSPVNTKSLF KRLYSLALHP NAFKRLGASL 1080
AFNNIYREFR EEESLVEQFV FEALVIYMES LALAHADEKS LGTIQQCCDA IDHLCRIIEK 1140
KHVSLNKAKK RRLPRGFPPS ASLCLLDLVK WLLAHCGRPQ TECRHKSIEL FYKFVPLLPG 1200
NRSPNLWLKD VLKEEGVSFL INTFEGGGCG QPSGILAQPT LLYLRGPFSL QATLCWLDLL 1260
LAALECYNTF IGERTVGALQ VLGTEAQSSL LKAVAFFLES IAMHDIIAAE KCFGTGAAGN 1320
RTSPQEGERY NYSKCTVVVR IMEFTTTLLN TSPEGWKLLK KDLCNTHLMR VLVQTLCEPA 1380
SIGFNIGDVQ VMAHLPDVCV NLMKALKMSP YKDILETHLR EKITAQSIEE LCAVNLYGPD 1440
AQVDRSRLAA VVSACKQLHR AGLLHNILPS QSTDLHHSVG TELLSLVYKG IAPGDERQCL 1500
PSLDLSCKQL ASGLLELAFA FGGLCERLVS LLLNPAVLST ASLGSSQGSV IHFSHGEYFY 1560
SLFSETINTE LLKNLDLAVL ELMQSSVDNT KMVSAVLNGM LDQSFRERAN QKHQGLKLAT 1620
TILQHWKKCD SWWAKDSPLE TKMAVLALLA KILQIDSSVS FNTSHGSFPE VFTTYISLLA 1680
DTKLDLHLKG QAVTLLPFFT SLTGGSLEEL RRVLEQLIVA HFPMQSREFP PGTPRFNNYV 1740
DCMKKFLDAL ELSQSPMLLE LMTEVLCREQ QHVMEELFQS SFRRIARRGS CVTQVGLLES 1800
VYEMFRKDDP RLSFTRQSFV DRSLLTLLWH CSLDALREFF STIVVDAIDV LKSRFTKLNE 1860
STFDTQITKK MGYYKILDVM YSRLPKDDVH AKESKINQVF HGSCITEGNE LTKTLIKLCY 1920
DAFTENMAGE NQLLERRRLY HCAAYNCAIS VICCVFNELK FYQGFLFSEK PEKNLLIFEN 1980
LIDLKRRYNF PVEVEVPMER KKKYIEIRKE AREAANGDSD GPSYMSSLSY LADSTLSEEM 2040
SQFDFSTGVQ SYSYSSQDPR PATGRFRRRE QRDPTVHDDV LELEMDELNR HECMAPLTAL 2100
VKHMHRSLGP PQGEEDSVPR DLPSWMKFLH GKLGNPIVPL NIRLFLAKLV INTEEVFRPY 2160
AKHWLSPLLQ LAASENNGGE GIHYMVVEIV ATILSWTGLA TPTGVPKDEV LANRLLNFLM 2220
KHVFHPKRAV FRHNLEIIKT LVECWKDCLS IPYRLIFEKF SGKDPNSKDN SVGIQLLGIV 2280
MANDLPPYDP QCGIQSSEYF QALVNNMSFV RYKEVYAAAA EVLGLILRYV MERKNILEES 2340
LCELVAKQLK QHQNTMEDKF IVCLNKVTKS FPPLADRFMN AVFFLLPKFH GVLKTLCLEV 2400
VLCRVEGMTE LYFQLKSKDF VQVMRHRDDE RQKVCLDIIY KMMPKLKPVE LRELLNPVVE 2460
FVSHPSTTCR EQMYNILMWI HDNYRDPESE TDNDSQEIFK LAKDVLIQGL IDENPGLQLI 2520
IRNFWSHETR LPSNTLDRLL ALNSLYSPKI EVHFLSLATN FLLEMTSMSP DYPNPMFEHP 2580
LSECEFQEYT IDSDWRFRST VLTPMFVETQ ASQGTLQTRT QEGSLSARWP VAGQIRATQQ 2640
QHDFTLTQTA DGRSSFDWLT GSSTDPLVDH TSPSSDSLLF AHKRSERLQR APLKSVGPDF 2700
GKKRLGLPGD EVDNKVKGAA GRTDLLRLRR RFMRDQEKLS LMYARKGVAE QKREKEIKSE 2760
LKMKQDAQVV LYRSYRHGDL PDIQIKHSSL ITPLQAVAQR DPIIAKQLFS SLFSGILKEM 2820
DKFKTLSEKN NITQKLLQDF NRFLNTTFSF FPPFVSCIQD ISCQHAALLS LDPAAVSAGC 2880
LASLQQPVGI RLLEEALLRL LPAELPAKRV RGKARLPPDV LRWVELAKLY RSIGEYDVLR 2940
GIFTSEIGTK QITQSALLAE ARSDYSEAAK QYDEALNKQD WVDGEPTEAE KDFWELASLD 3000
CYNHLAEWKS LEYCSTASID SENPPDLNKI WSEPFYQETY LPYMIRSKLK LLLQGEADQS 3060
LLTFIDKAMH GELQKAILEL HYSQELSLLY LLQDDVDRAK YYIQNGIQSF MQNYSSIDVL 3120
LHQSRLTKLQ SVQALTEIQE FISFISKQGN LSSQVPLKRL LNTWTNRYPD AKMDPMNIWD 3180
DIITNRCFFL SKIEEKLTPL PEDNSMNVDQ DGDPSDRMEV QEQEEDISSL IRSCKFSMKM 3240
KMIDSARKQN NFSLAMKLLK ELHKESKTRD DWLVSWVQSY CRLSHCRSRS QGCSEQVLTV 3300
LKTVSLLDEN NVSSYLSKNI LAFRDQNILL GTTYRIIANA LSSEPACLAE IEEDKARRIL 3360
ELSGSSSEDS EKVIAGLYQR AFQHLSEAVQ AAEEEAQPPS WSCGPAAGVI DAYMTLADFC 3420
DQQLRKEEEN ASVIDSAELQ AYPALVVEKM LKALKLNSNE ARLKFPRLLQ IIERYPEETL 3480
SLMTKEISSV PCWQFISWIS HMVALLDKDQ AVAVQHSVEE ITDNYPQAIV YPFIISSESY 3540
SFKDTSTGHK NKEFVARIKS KLDQGGVIQD FINALDQLSN PELLFKDWSN DVRAELAKTP 3600
VNKKNIEKMY ERMYAALGDP KAPGLGAFRR KFIQTFGKEF DKHFGKGGSK LLRMKLSDFN 3660
DITNMLLLKM NKDSKPPGNL KECSPWMSDF KVEFLRNELE IPGQYDGRGK PLPEYHVRIA 3720
GFDERVTVMA SLRRPKRIII RGHDEREHPF LVKGGEDLRQ DQRVEQLFQV MNGILAQDSA 3780
CSQRALQLRT YSVVPMTSRL GLIEWLENTV TLKDLLLNTM SQEEKAAYLS DPRAPPCEYK 3840
DWLTKMSGKH DVGAYMLMYK GANRTETVTS FRKRESKVPA DLLKRAFVRM STSPEAFLAL 3900
RSHFASSHAL ICISHWILGI GDRHLNNFMV AMETGGVIGI DFGHAFGSAT QFLPVPELMP 3960
FRLTRQFINL MLPMKETGLM YSIMVHALRA FRSDPGLLTN TMDVFVKEPS FDWKNFEQKM 4020
LKKGGSWIQE INVAEKNWYP RQKICYAKRK LAGANPAVIT CDELLLGHEK APAFRDYVAV 4080
ARGSKDHNIR AQEPESGLSE ETQVKCLMDQ ATDPNILGRT WEGWEPWM 4128 
Gene Ontology
 GO:0005958; C:DNA-dependent protein kinase-DNA ligase 4 complex; IDA:MGI.
 GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
 GO:0005667; C:transcription factor complex; IDA:BHF-UCL.
 GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
 GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
 GO:0004677; F:DNA-dependent protein kinase activity; IDA:MGI.
 GO:0006915; P:apoptotic process; IEA:Compara.
 GO:0002326; P:B cell lineage commitment; IEA:Compara.
 GO:0007420; P:brain development; IEA:Compara.
 GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL.
 GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:Reactome.
 GO:0035234; P:germ cell programmed cell death; IEA:Compara.
 GO:0007507; P:heart development; IEA:Compara.
 GO:0033152; P:immunoglobulin V(D)J recombination; IEA:Compara.
 GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL.
 GO:0043065; P:positive regulation of apoptotic process; IEA:Compara.
 GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
 GO:0002328; P:pro-B cell differentiation; IEA:Compara.
 GO:0031648; P:protein destabilization; IEA:Compara.
 GO:0010332; P:response to gamma radiation; IEA:Compara.
 GO:0001756; P:somitogenesis; IEA:Compara.
 GO:0033077; P:T cell differentiation in thymus; IEA:Compara.
 GO:0002360; P:T cell lineage commitment; IEA:Compara.
 GO:0033153; P:T cell receptor V(D)J recombination; IEA:Compara.
 GO:0000723; P:telomere maintenance; IEA:Compara. 
Interpro
 IPR011989; ARM-like.
 IPR016024; ARM-type_fold.
 IPR003152; FATC.
 IPR011009; Kinase-like_dom.
 IPR012582; NUC194.
 IPR000403; PI3/4_kinase_cat_dom.
 IPR018936; PI3/4_kinase_CS.
 IPR003151; PIK-rel_kinase_FAT.
 IPR014009; PIK_FAT. 
Pfam
 PF02259; FAT
 PF02260; FATC
 PF08163; NUC194
 PF00454; PI3_PI4_kinase 
SMART
 SM00146; PI3Kc 
PROSITE
 PS51189; FAT
 PS51190; FATC
 PS50077; HEAT_REPEAT
 PS00915; PI3_4_KINASE_1
 PS00916; PI3_4_KINASE_2
 PS50290; PI3_4_KINASE_3
 PS50005; TPR
 PS50293; TPR_REGION 
PRINTS